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Assessment of mitral valve area by 3D echocardi-
ography in rheumatic mitral stenosis: Validation
of offline 3D planimetry measure
Alaa A. Mohamed, Ahmad Omran, MA. Hussein
Objectives: The aim of this study is to validate the
feasibility and accuracy of performing offline planimetric
measurement of mitral valve area (MVA) using real time
3-dimensional transesophageal echocardiography (3D
TEE), and to compare it with methods used routinely in
clinical practice: 2-dimensional (2D) planimetry and pres-
sure half time (PHT).
Background: Measurements of MVA by (2D) pla-
nimetry and Doppler (PHT) remain the mainstay meth-
ods used in routine clinical practice. 3D TEE provides
more improved accuracy and reproducibility over 2D
methods in theassessment of mitral valve morphology.
Planimetry of the MVA by 3D echocardiography has only
been done through multi-planar reconstruction of the
mitral valve orifice. However using offline 2D image cal-
ibration and measurement tools allows us to measure
MVA by 3D planimetry.
Methods: 45 patients with moderate to severe rheu-
matic mitral stenosis were referred for transthoracic and
transesophageal (TEE) echocardiography 2D and 3D. Off-
line planimetric measurement of MVA obtained from
real time 3D TEE zoom views of the mitral valve from
both left atrial (MVA 3DPLA) and left ventricular side
(MVA 3DPLV) were compared to MVA by 2D planimetry
and PHT. MVA measurements (2D and 3D) were
reported by two independent readers and interobserver
variability was assessed. MV areas measured by these
three methods were compared using Altman and Bland
methods and Shukla’s correlation.
Results: The Altman and bland analysis showed
consistency among all three measurements methods. 3
DTEE showed the least variability across different clini-
cians compared to 2 DTEE and PHT, Mean difference
0.08, 0.15, and .17, respectively.
Conclusion: 3DTEE planimetry appears to be a con-
sistent technique for measuring MVA and provides the
least variability in practical setting.
http://dx.doi:10.1016/j.jsha.2013.03.047
Kawasaki disease, delayed referral as a cause of
coronary artery affection
Ali A. Al-akhfash, Marwan Al Hawbani,
Abdulrahman A. Almesnid
Kawasaki disease (KD), an acute febrile vasculitis, is
the most common cause of acquired heart disease in
infants and young children. However, the diagnosis of
infantile KD can be difficult or delayed due to vague clin-
ical manifestations. This current study aimed to review
patients referred to pediatric cardiology at PSCC-Qassim
with a diagnosis or suspicion of Kaawasaki disease.
Methods: Retospectively review of the database as
well as patients files.
Results: During the period from August till 2009
August 2012, 23 patients were referred to PSCC-Q, with
a mean F/U period of 32 months. The mean age of pre-
sentation ±SD was 32 ± 28 months (range 5–96 months).
The timing of referral was ranging from 2 to 30 days from
the onset of fever. 13 patients were having complete cri-
teria for Kawasaki on presentation, 8 of them developed
cardiac affection. Out of the 22 patients referred 12 had
cardiac abnormality in the form of mitral insufficiency
in 2, aortic root dilatation in one and coronary artery
involvement in 6 patients. All patients except one
received IgG at a mean time from onset of fever of
10 ± 6 days (range 5–30 days). Two patients required a
second dose of IgG after 48 h from the first dose. Initial
echo was normal in 13. The most commonly affected cor-
onary artery was the LAD. ECG was abnormal in one.
Comparison between the groups with and without car-
diac affection was done. There was a difference in all
variables but did not reach a statistically significant
value.
Conclusion: A significant number of patients with
complete as well as incomplete Kawasaki had cardiac
involvement especially coronary atery affection. Delay
in the referral as well as in the administration of IgG
may lead to developement of coronary artery
involvement.
http://dx.doi:10.1016/j.jsha.2013.03.048
Survival outcome of 100 patients who underwent
transcatheter aortic valve implantation (TAVI)
Saeed Al Ahmari, Mohammed Al Otabi, Ali Al
Masood, Ahmed El Watidi, Moheeb Al Abdullah,
Husien Al Amri, Saad Al Kasab
Background: TAVI is a new alternative treatment
for high risk patients with severe aortic stenosis (AS).
The procedural success and survival have improved
over time. We report the survival data of 100 patients
who received TAVI at Prince Sultan Cardiac Center,
Riyadh.
Methods: Patient’s clinical, imaging and procedural
data were collected in a data base, and they were fol-
lowed at 6 month and yearly afterward. The survival data
were derived using statistical software
Results: 100 patients underwent the procedure with
mean age of 78.8 ± 8.8 years, 55% males, and 45 %
females. 60% of patient received Edward’s valve, and
40% received Core valve. The procedural success was
95%. The 30 days mortality was 10% in patients who
received Edward’s valve, and 5% in those received Core
valve. The 1-year mortality was 21% in patients received
Edward valve and 10% in those received Core valve. The
30 days mortality for patients who had trans-femoral
Edward approach was 9%, and for those who had
trans-apical approach was 11%. The 1-year mortality for
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trans-femoral Edward approach was 15%, and for the
trans-apical approach was 30%.
Conclusion: Elderly patients with severe AS and at
high risk for surgery can undergo TAVI with high success
rate, and acceptable mortality rate. The highest mortality
rate at 1 year was in patients who underwent trans-apical
TAVI.
http://dx.doi:10.1016/j.jsha.2013.03.049
Chest pain in paediatric patients referred to paedi-
atric cardiology clinic at PSCC qassim
Ali A. Al-Akhfash, Abdulrahman A. Almesnid,
Zuhair Aalem, Suleiman Almesned
Chest pain is a common paediatric complaint. Chest
pain due to a cardiac condition is rare in children and
adolescents, with a prevalence of less than 6%. History
and physical exam may be sufficient for identifying the
majority of significant aetiologies.
Objectives: To review the different causes of chest
pain of patients referred to PSCC-Q
Method: Rertrospective analysis of our database. Fol-
low up of patients was done with telephone call of all
patients family to ask about the child and the chest pain
status.
Results: During the period from January 2011 till
December 2012, 28 patients were referred because of
chest pain to the cardiac clinic. 18 (64%) were females
and 10 (36%) were males. Palpitations were present in 7
of them (25%). Four patients were having noncardiac
symptoms in the form of arthralgia in two and recurrent
tonsillitis in two. Tow patients were having a positive
family history of cardiac problems in the form of mitral
valve prolapse in one and dilated cardiomyopathy in
the other. General examination and Vital signs were nor-
mal in all of them. The mean ± SD of the heart rate, blood
pressure and saturation were 99 ± 15 bpm, 102/63 ± 11/
9 mm Hg, and 97 ± 1% respectively. The mean ± SD of
the weight and height were 30 ± 16 kg and 131 ± 10 cm,
respectively. Cardiovascular examination was normal in
all of them. Innocent systolic murmur was present in 5
of them (18%). ECG was also normal in all of them.
One patient had mild prolongation of the PR interval.
Those with history of palpitations had Holter monitoring
for 24 h which were normal in all of them. Chest pain was
recurrent in 6 patients (22%) and was related to exertion
in only one. On Followup all patients were alive and
asymptomatic.
Conclusion: Chest pain in children usually is
benign. History and physical exam usually are sufficient.
Laboratory testing should be guided by History and
physical exam.
http://dx.doi:10.1016/j.jsha.2013.03.050
Improvement in door-to-balloon time at King
Abdulaziz Cardiac Center: Are we achieving the
goal?
Ali M. Alghamdi, Mohammed Balgaith, Kamal
Ayoub, Basil Saeed, Ahmed Sailik, Muyed Alzaibag
Background: Early reperfusion in acute ST-segment
elevation myocardial infarction (STEMI) is very impor-
tant to improve patients clinical outcome. Implementing
institutional plan to decrease door-to-balloon time is cru-
cial to achieve this goal. Our goal is to met the ACC/AHA
recommendations of door-to-balloon time <90 min.
Methods: A chart review of all cases of primary per-
cutaneous coronary intervention (PCI) for ST-segment
elevation myocardial infarction (STEMI) performed. All
door-to-balloon times were recorded. The average door-
to-balloon time was calculated.
Results: 536 patients underwent primary PCI for
STEMI from September 3, 2008–Sept 30, 2012. For each
patient, the initial presenting time, the first ECG time,
the time ER physician saw the patient and activate the
cath lab, the time patient arrived to cath lab, and punc-
ture time to balloon inflation were recorded. 52 patients
were excluded from the study for not having clear
door-to-balloon time. 64.2% of the patients met the
ACC/AHA recommendation of <90 min door-to-balloon
time. The average door-to-balloon time was 87.7
(STD + 35.5) minutes for all patients. There was signifi-
cant improvement in door-to-balloon time from2008 to
2012. Average door-to-balloon time reduced from
105 min in September 2008–December 2009 to 72 min in
2012. In 2012 door-to-balloon time was below 90 minutes
in 86% of patients versus 46% in September 2008–Decem-
ber 2009.
Conclusion: Sixty-four percent of patients under-
went primary PCI in King Abdulaziz Cardiac Center
met the recommended guidelines. In 2012, 86% met the
recommended guidelines. Our future goal is to achieve
the recommended guidelines in all patients.
http://dx.doi:10.1016/j.jsha.2013.03.051
Incidence of in-stent re-stenosis with CATANIA
Coronary Stent
Rahim Gul, M. Alotaibi, Kazim Hameedullah,
Hussein Al Amri, Ali AlMasood, Moheeb Alabdalah,
Abdulah AlKhushail, Abdulrahman Al Moghairi
Objectives: The study sought to assess safety and
efficacy of implantation of CATANIA Coronary Stent.
Background: CATANIA Coronary Stent is new
stents coated with an inorganic, high molecular weight
polymer Polyzene F. It is a flexible cobalt chromium bal-
loon expandable stent. Polyzine-F was claimed to have
low surface thrombogenicity, anti-inflammatory,
bacterial resistance, and pro healing effects which result
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